Zhejiang Jingxin Pharmaceutical Co., Ltd. (SHE:002020)
China
· Delayed Price · Currency is CNY 13.65
0.00 (0.00%)
Apr 30, 2025, 3:04 PM CST
SHE:002020 Revenue
In the year 2024, Zhejiang Jingxin Pharmaceutical had annual revenue of 4.16B CNY with 3.99% growth. Zhejiang Jingxin Pharmaceutical had revenue of 949.81M in the quarter ending December 31, 2024, a decrease of -11.51%.
Revenue
4.16B
Revenue Growth
+3.99%
P/S Ratio
2.90
Revenue / Employee
1.04M
Employees
3,909
Market Cap
11.75B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.16B | 159.72M | 3.99% |
| Dec 31, 2023 | 4.00B | 218.99M | 5.79% |
| Jan 1, 2023 | 3.78B | 313.30M | 9.04% |
| Jan 1, 2022 | 3.47B | 208.47M | 6.40% |
| Dec 31, 2020 | 3.26B | -388.61M | -10.66% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Aier Eye Hospital Group | 21.81B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |